Georg Rueedi

411 total citations
12 papers, 271 citations indexed

About

Georg Rueedi is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Georg Rueedi has authored 12 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 3 papers in Infectious Diseases. Recurrent topics in Georg Rueedi's work include Cancer therapeutics and mechanisms (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Georg Rueedi is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Georg Rueedi collaborates with scholars based in Switzerland. Georg Rueedi's co-authors include Daniel Ritz, Daniel Bur, Peter Seiler, Thierry Bruyère, Christian Hubschwerlen, Hans H. Locher, Patrick Caspers, Philippe Panchaud, Eric A. Ertel and Sylvia Richard‐Bildstein and has published in prestigious journals such as Angewandte Chemie International Edition, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Georg Rueedi

12 papers receiving 265 citations

Peers

Georg Rueedi
Kelvin J. Y. Wu United States
Peter N. Carlsen United States
Melanie Clifford United Kingdom
Jeremy D. Mason United States
Georg Rueedi
Citations per year, relative to Georg Rueedi Georg Rueedi (= 1×) peers Matthew J. Mitcheltree

Countries citing papers authored by Georg Rueedi

Since Specialization
Citations

This map shows the geographic impact of Georg Rueedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Rueedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Rueedi more than expected).

Fields of papers citing papers by Georg Rueedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Rueedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Rueedi. The network helps show where Georg Rueedi may publish in the future.

Co-authorship network of co-authors of Georg Rueedi

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Rueedi. A scholar is included among the top collaborators of Georg Rueedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Rueedi. Georg Rueedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lange, Roland, et al.. (2025). Measurement and prediction of small molecule retention by Gram-negative bacteria based on a large-scale LC/MS screen. Scientific Reports. 15(1). 25431–25431. 2 indexed citations
2.
Rueedi, Georg, Philippe Panchaud, Jean‐Luc Specklin, et al.. (2024). Discovery and Structure–Activity Relationship of Cadazolid: A First-In-Class Quinoxolidinone Antibiotic for the Treatment of Clostridioides difficile Infection. Journal of Medicinal Chemistry. 67(11). 9465–9484. 5 indexed citations
3.
Caspers, Patrick, et al.. (2020). Synthesis and Structure‐Activity Relationship of Xenocoumacin 1 and Analogues as Inhibitors of Ribosomal Protein Synthesis. ChemMedChem. 16(5). 891–897. 6 indexed citations
4.
Panchaud, Philippe, Jean‐Philippe Surivet, Stefan Diethelm, et al.. (2019). Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration. Journal of Medicinal Chemistry. 63(1). 88–102. 14 indexed citations
5.
Scaiola, Alain, Marc Leibundgut, Daniel Boehringer, et al.. (2019). Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic. Scientific Reports. 9(1). 5634–5634. 19 indexed citations
6.
Caspers, Patrick, Katja Zerbe, Hideki Miyatake‐Ondozabal, et al.. (2018). Total Synthesis and Biological Evaluation of the Glycosylated Macrocyclic Antibiotic Mangrolide A. Angewandte Chemie International Edition. 57(34). 11020–11024. 25 indexed citations
7.
Caspers, Patrick, Katja Zerbe, Hideki Miyatake‐Ondozabal, et al.. (2018). Total Synthesis and Biological Evaluation of the Glycosylated Macrocyclic Antibiotic Mangrolide A. Angewandte Chemie. 130(34). 11186–11190. 9 indexed citations
9.
Panchaud, Philippe, Thierry Bruyère, Daniel Bur, et al.. (2017). Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents. Journal of Medicinal Chemistry. 60(9). 3755–3775. 80 indexed citations
10.
Caspers, Patrick, Hans H. Locher, Sarah Diggelmann, et al.. (2017). Different Resistance Mechanisms for Cadazolid and Linezolid in Clostridium difficile Found by Whole-Genome Sequencing Analysis. Antimicrobial Agents and Chemotherapy. 61(8). 9 indexed citations
11.
Surivet, Jean‐Philippe, Thierry Bruyère, Daniel Bur, et al.. (2017). Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria. Journal of Medicinal Chemistry. 60(9). 3776–3794. 26 indexed citations
12.
Surivet, Jean‐Philippe, Georg Rueedi, Christian Hubschwerlen, et al.. (2013). Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity. Journal of Medicinal Chemistry. 56(18). 7396–7415. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026